Actively Recruiting
Evaluating Safety and Effectiveness of Thermage FLX Radiofrequency for Improving Skin Lines, Wrinkles, and Laxity on Neck, Abdomen, Upper Arms, and Face
Led by Bausch Health Americas, Inc. · Updated on 2026-08-26
164
Participants Needed
7
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective, 180-day controlled study to evaluate the safety and effectiveness of the Thermage FLX System, a radiofrequency device, for improving lines, wrinkles, and skin laxity in adults aged 30 to 60 years. The study aims to demonstrate that treatment with the Thermage FLX System is superior to no treatment in improving skin appearance on the neck, abdomen, upper arms, and face. This multicenter trial enrolls 164 participants across sites in North America and China. Participants are randomly assigned to receive treatment with the Thermage FLX device either at day 1 or day 90, or to an untreated control group. The Thermage FLX System is a monopolar radiofrequency device used in non-invasive dermatological procedures targeting mild-to-moderate skin laxity and wrinkles. The study includes a 6-month 26-week period during which safety, tolerability, and improvements in skin appearance are evaluated. During the study, participants undergo assessments at baseline and follow-up visits to monitor changes in skin lines, wrinkles, and laxity using standardized scales. Safety and tolerability are carefully evaluated throughout the study. Participants must comply with study instructions, attend scheduled visits, and avoid other cosmetic procedures on treatment areas during the trial. The primary outcome is measured at 90 days, with secondary assessments at 180 days.
CONDITIONS
Brief Title
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
Research Team
S
Sandra Narain
C
Caitlin Little
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here